Jack Henry & Associates, Inc.® (Nasdaq: JKHY) announced today that it will be participating in the following upcoming conference: Greg Adelson, President & CEO, will present at Bernstein's 41st...

The National Institute of Building Sciences (NIBS) recognized outstanding contributions to the built environment during an awards luncheon at Building Innovation 2025 (BI2025), one of the premier...

Bantam Pharmaceutical, a drug discovery and development company targeting selective modulation of mitochondrial dynamics in cancer, today announced that its Trial in Progress abstract has been...

Final data from the GAVRETO® (pralsetinib) Phase 1/2 ARROW study in RET fusion-positive NSCLC and other solid tumors Supportive data for REZLIDHIA® (olutasidenib) utilization in patients with...

Data will be shared in two oral presentations, a poster and two online abstracts Highlights include a potential novel, all-oral therapy for AML; and Phase 2 data for a novel treatment targeting...

Servier today announced that it will present updates from its research programs at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting on May 30 – June 3 in Chicago....

The data shows the prognostic value of Foresight CLARITY MRD detection at the end of frontline DLBCL in one of its largest prospective, real-world studies to date Data will be presented as an oral...

ATX-559, a first-in-class oral DHX9 inhibitor, is being evaluated in a Phase 1/2 study with a focus on advanced or metastatic patients with BRCA-1 and/or BRCA-2-deficient breast cancer or MSI-H...

The Bank of New York Mellon Corporation ("BNY") (NYSE: BK), a global financial services company, today announced that Jim Crowley, Global Head of BNY Pershing, will speak at the Morgan Stanley...

Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate in the Stifel 2025 Jaws & Paws Conference. The fireside chat will take place on Wednesday,...